ViiV Archives -

How to make digital adoption a smooth journey

https://pharmaphorum.com/views-analysis-sales-marketing/digital-adoption-smooth-journey/

ViiV’s injection still suppresses HIV when taken every two months – study

https://pharmaphorum.com/news/viivs-injection-still-suppresses-hiv-when-taken-every-two-months-study/

ViiV hails data showing switch from Truvada to two-drug HIV regimen

https://pharmaphorum.com/news/viiv-hails-data-showing-switch-from-truvada-to-two-drug-hiv-regimen/

ViiV’s Dovato HIV pill approved in EU

https://pharmaphorum.com/news/viivs-dovato-hiv-pill-approved-in-eu/

ViiV hopes for blockbuster with HIV drug combo approval

https://pharmaphorum.com/news/viiv-hopes-blockbuster-hiv-drug-combo-approval/

R&D round-up: Non-opioid painkiller space heats up

https://pharmaphorum.com/views-and-analysis/rd-roundup-non-opioid-painkiller-space-heats-up/

Once-a-month HIV treatment sees promising phase III results

https://pharmaphorum.com/news/once-a-month-hiv-treatment-sees-promising-phase-iii-results/

ViiV redeems voucher for fast FDA review of HIV combination

https://pharmaphorum.com/news/viiv-redeems-voucher-for-fast-fda-review-of-hiv-combination/

GSK’s blockbuster HIV drug linked with birth defects

https://pharmaphorum.com/news/gsk-blockbuster-hiv-drug-linked-with-birth-defects/

Search